Gilead Sciences (GILD) acquires Tubulis for $5B to expand cancer drug pipeline. RBC raises target to $123 as analysts watch Yeztugo performance ahead of Q1.
Browsing: Stocks
UnitedHealth (UNH) stock climbed after the government approved a 2.48% Medicare Advantage rate increase for 2027, well above the 0.09% initial proposal.
DoorDash (DASH) director sells $3.47M in shares as insiders dump $18.3M. Stock down 45% from peak despite Buy ratings and $263 average price target.
Deere (DE) settles right-to-repair lawsuit for $99M, granting farmers 10-year access to repair tools and diagnostics. FTC case ongoing.
Arm Holdings (ARM) stock dropped 3.7% after Morgan Stanley’s downgrade to Equal-Weight, citing near-term demand challenges and margin pressures ahead.
Oracle (ORCL) stock names Hilary Maxson as CFO. Wall Street analysts praise the infrastructure-focused hire as capex targets $50B for fiscal 2026.
Biogen (BIIB) partners with Alloy Therapeutics for antisense oligonucleotide drug development. RBC Capital lowers price target to $213 but maintains Outperform rating.
Google unveils mental health crisis tools for Gemini AI and pledges $30M to global hotlines. New features include one-touch crisis support access.
Silo Pharma (SILO) stock surged 47% after-hours as the European Patent Office signaled intent to grant its PTSD prevention therapy patent.
Delta Air Lines (DAL) reports Q1 earnings Wednesday. Analysts expect $14.94B revenue, $0.58 EPS. Fuel costs and summer bookings are key focus areas.